These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers. Lopes JM; Hannisdal E; Bjerkehagen B; Bruland OS; Danielsen HE; Pettersen EO; Sobrinho-Simões M; Nesland JM Anal Cell Pathol; 1998; 16(1):45-62. PubMed ID: 9584899 [TBL] [Abstract][Full Text] [Related]
3. Epithelioid sarcoma. Flow cytometric study of DNA content and regional DNA heterogeneity. el-Naggar AK; Garcia GM Cancer; 1992 Apr; 69(7):1721-8. PubMed ID: 1551057 [TBL] [Abstract][Full Text] [Related]
4. Correlation between DNA ploidy, metaphase high-resolution comparative genomic hybridization results and clinical outcome of synovial sarcoma. Balogh Z; Szemlaky Z; Szendroi M; Antal I; Pápai Z; Fónyad L; Papp G; Changchien YC; Sápi Z Diagn Pathol; 2011 Nov; 6():107. PubMed ID: 22053830 [TBL] [Abstract][Full Text] [Related]
5. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923 [TBL] [Abstract][Full Text] [Related]
6. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040 [TBL] [Abstract][Full Text] [Related]
7. Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features. van de Rijn M; Barr FG; Xiong QB; Hedges M; Shipley J; Fisher C Am J Surg Pathol; 1999 Jan; 23(1):106-12. PubMed ID: 9888710 [TBL] [Abstract][Full Text] [Related]
8. Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma. Kawauchi S; Goto Y; Liu XP; Furuya T; Oga A; Oda Y; Tsuneyoshi M; Ihara K; Sasaki K Cancer; 2001 Mar; 91(5):1005-12. PubMed ID: 11251953 [TBL] [Abstract][Full Text] [Related]
9. Real-time polymerase chain reaction as an aid for the detection of SYT-SSX1 and SYT-SSX2 transcripts in fresh and archival pediatric synovial sarcoma specimens: report of 25 cases from St. Jude Children's Research Hospital. Hill DA; Riedley SE; Patel AR; Shurtleff SA; Hyer J; Cain AM; Billups CA; Downing JR; Pappo AS Pediatr Dev Pathol; 2003; 6(1):24-34. PubMed ID: 12469233 [TBL] [Abstract][Full Text] [Related]
10. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression. ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619 [TBL] [Abstract][Full Text] [Related]
11. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients. Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594 [TBL] [Abstract][Full Text] [Related]
12. DNA content as a predictor of clinical outcome in soft tissue sarcoma patients. Budach W; Budach V; Socha B; Stuschke M; Streffer C; Sack H Eur J Cancer; 1994; 30A(12):1815-21. PubMed ID: 7880612 [TBL] [Abstract][Full Text] [Related]
14. [Monophasic fibrous synovial sarcoma of the hand with biphasic differentiated lung metastases]. Lotz S; Caselitz J; Bullerdiek J; Rieckhoff KU Pathologe; 1993 Jan; 14(1):54-7. PubMed ID: 8383847 [No Abstract] [Full Text] [Related]
15. Fine needle aspiration (FNA) of synovial sarcoma--a comparative histological-cytological study of 15 cases, including immunohistochemical, electron microscopic and cytogenetic examination and DNA-ploidy analysis. Akerman M; Willén H; Carlén B; Mandahl N; Mertens F Cytopathology; 1996 Jun; 7(3):187-200. PubMed ID: 8782991 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins. Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935 [TBL] [Abstract][Full Text] [Related]
17. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. Spillane AJ; A'Hern R; Judson IR; Fisher C; Thomas JM J Clin Oncol; 2000 Nov; 18(22):3794-803. PubMed ID: 11078492 [TBL] [Abstract][Full Text] [Related]
18. Synovial sarcoma: the importance of size and location for survival. Deshmukh R; Mankin HJ; Singer S Clin Orthop Relat Res; 2004 Feb; (419):155-61. PubMed ID: 15021147 [TBL] [Abstract][Full Text] [Related]
19. Synovial sarcoma. A clinicopathological study of 31 cases. Santavirta S Arch Orthop Trauma Surg; 1992; 111(3):155-9. PubMed ID: 1316772 [TBL] [Abstract][Full Text] [Related]
20. DNA content and morphological parameters in synovial sarcoma and synovioma. Lu C; Xia J; Yang M Chin Med J (Engl); 1995 Oct; 108(10):760-3. PubMed ID: 8565662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]